title: [Update in interleukin-1 inhibition].
authors.affiliation: Service de médecine interne, centre hospitalier Robert-Bisson, 4, rue Roger-Aini, 14100 Lisieux, France. hubertdeboysson@yahoo.fr
authors.forename: H
authors.initials: H
authors.lastname: de Boysson
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002352:Carrier Proteins / Q000235:genetics; D002908:Chronic Disease; D056587:Cryopyrin-Associated Periodic Syndromes / Q000188:drug therapy* / Q000235:genetics; D031249:Erdheim-Chester Disease / Q000188:drug therapy; D010505:Familial Mediterranean Fever / Q000188:drug therapy; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D007375:Interleukin-1 / Q000037:antagonists & inhibitors*; D053582:Interleukin-1alpha / Q000037:antagonists & inhibitors; D053583:Interleukin-1beta / Q000037:antagonists & inhibitors; D009154:Mutation; D000071199:NLR Family, Pyrin Domain-Containing 3 Protein; D010493:Pericarditis / Q000188:drug therapy; D011081:Polychondritis, Relapsing / Q000188:drug therapy; D019873:Schnitzler Syndrome / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D002352:Carrier Proteins; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1; D053582:Interleukin-1alpha; D053583:Interleukin-1beta; D000071199:NLR Family, Pyrin Domain-Containing 3 Protein; C453881:NLRP3 protein, human